Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
Regencell Bioscience Holdings L
RGC
$6.17
Name : Regencell Bioscience Holdings L
Sector : Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Mark. Cap: $0.00000000000000
EPSttm : -0.01
finviz dynamic chart for RGC
Regencell Bioscience Holdings L
$6.17
0.00%
$0.00000000000000
RGC — Price & Float Short
—— Fair value ★ EPS beat ★ EPS miss —— Target Price
Float Short %

Float Short %

1.43

Margin Of Safety %

Put/Call OI Ratio

2.49

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

Price

6.2

Target Price

Analyst Recom

Performance Q

-4.78

Upside

-102.1%

Beta

1.16

Ticker: RGC




20 items of 1

DateSymbolLatestP/C OIP/C VolTotal OI
2026-08-28RGC5.541.840.146007
2026-08-31RGC5.491.830.006018
2026-09-01RGC5.51.70196936542673.56174
2026-09-02RGC6.31.700.116178
2026-09-03RGC6.421.640.106280
2026-09-04RGC6.81.580.006383
2026-09-08RGC6.841.510.016485
2026-09-09RGC5.831.500.136516
2026-09-10RGC5.631.490.336537
2026-09-11RGC5.611.490.506542
2026-09-14RGC5.711.486.006537
2026-09-15RGC5.5851.480.006533
2026-09-16RGC5.661.471.216519
2026-09-17RGC5.941.4764.006524
2026-09-18RGC5.761.490.646583
2026-09-21RGC5.922.330.404647
2026-09-22RGC6.232.280.524727
2026-09-23RGC6.012.2759.154763
2026-09-24RGC6.172.500.005090
2026-09-25RGC6.162.490.005094
DateSymbolLatestP/C OIP/C VolTotal OI
20 items Current Page1 of 1




20 items of 1

DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
2026-08-28RGC5.55- - -
2026-08-31RGC5.53- - -
2026-09-01RGC5.47- - -
2026-09-02RGC6.22- - -
2026-09-03RGC6.52- - -
2026-09-04RGC6.76- - -
2026-09-08RGC6.73- - -
2026-09-09RGC5.81- - -
2026-09-10RGC5.61- - -
2026-09-11RGC5.64- - -
2026-09-14RGC5.72- - -
2026-09-15RGC5.56- - -
2026-09-16RGC5.56- - -
2026-09-17RGC5.96- - -
2026-09-18RGC5.75- - -
2026-09-21RGC5.86- - -
2026-09-22RGC6.26- - -
2026-09-23RGC5.97- - -
2026-09-24RGC6.15- - -
2026-09-25RGC6.20- - -
DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
20 items Current Page1 of 1




19 items of 1

DateTickerInsider TransactionsInstitutional TransactionsFloat Short
2026-08-28RGC0.0062.541.77
2026-08-31RGC0.0062.371.77
2026-09-01RGC0.0062.371.77
2026-09-02RGC0.0062.371.77
2026-09-03RGC0.0062.371.77
2026-09-04RGC0.0062.371.77
2026-09-08RGC0.0062.371.77
2026-09-09RGC0.0062.371.77
2026-09-10RGC0.0062.371.77
2026-09-11RGC0.0062.371.70
2026-09-14RGC0.0063.211.70
2026-09-15RGC0.0063.211.70
2026-09-16RGC0.0063.211.70
2026-09-17RGC0.0063.211.70
2026-09-18RGC0.0063.211.70
2026-09-21RGC0.0064.311.70
2026-09-23RGC0.0064.311.70
2026-09-24RGC0.0064.311.70
2026-09-25RGC0.0064.311.43
DateTickerInsider TransactionsInstitutional TransactionsFloat Short
19 items Current Page1 of 1

Last Quarter Act. EPS​

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

64.31

Beta

1.16

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

4

Growth Score

Sentiment Score

64

Actual DrawDown %

99.4

Max Drawdown 5-Year %

-99.5

Target Price

P/E

Forward P/E

PEG

P/S

P/B

2497.98

P/Free Cash Flow

EPS

-0.01

Average EPS Est. Cur. Y​

EPS Next Y. (Est.)

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

Relative Volume

0.16

Return on Equity vs Sector %

-100

Return on Equity vs Industry %

-100

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

◆ RGC Healthcare
$6.17
📉
Swing / Pullback
Buy the dip on strong trends
33 /100
WEAK
Trend
0/20
Pullback
13/25
Volume
11/15
Valuation
6/20
TP/AR
2/10
Options
1/10
RSI
53.2
Range 1M
38.5%
Sup Dist
3.2%
🚀
Momentum Growth
Ride accelerating trends
N/A
12 /100
WEAK
Momentum
0/25
Growth
4/30
Estimates
0/20
Inst/Vol
5/15
Options
3/10
EPS Yr
0%
EPS NY
0%
52W%
2.5%
💎
Long-Term Value
Quality companies, undervalued
N/A
0 /100
WEAK
Quality
2/30
Valuation
2/30
Growth
0/25
Stability
5/10
LT Trend
2/5
Quality
4
RGC — P/E HistoricalDrug Manufacturers - Specialty & Generic
Regencell Bioscience Holdings L
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Employees: 10
Regencell Bioscience Holdings Limited operates as a Traditional Chinese medicine (TCM) bioscience company in Hong Kong. It focuses on the research, development, and commercialization of TCM for the treatment of neurocognitive disorders and degeneration, primarily for attention deficit hyperactivity disorder and autism spectrum disorder. The company was incorporated in 2014 and is headquartered in Causeway Bay, Hong Kong.
RGC

Latest News

—
Caricamento notizie per RGC…
stock quote shares RGC – Regencell Bioscience Holdings Ltd Stock Price stock today
news today RGC – Regencell Bioscience Holdings Ltd stock forecast ,stock prediction 2023 2024 2025
marketwatch RGC – Regencell Bioscience Holdings Ltd yahoo finance google finance
stock history RGC – Regencell Bioscience Holdings Ltd invest stock market
stock prices RGC premarket after hours
ticker RGC fair value insiders trading